#1 Clinical Trials Search in Europe

Mifepristone

Mifepristone, also known as RU-486, is a medication that has been the subject of numerous clinical trials for its potential use in treating various medical conditions. Originally developed as an abortion pill, researchers have been exploring its efficacy in treating disorders such as bipolar depression, certain types of cancer, uterine fibroids, Cushing’s syndrome, and post-traumatic stress disorder. This article summarizes the key findings from several clinical trials investigating the use of mifepristone in different medical contexts.

Table of Contents

What is Mifepristone?

Mifepristone is a medication that has various uses in medical treatment. It’s known by several other names, including RU-486, Korlym®, Mifeprex, C1073, Corluxin™, and Corlux™[1][2]. This drug is primarily known for its ability to block certain hormones in the body, which makes it useful for treating various conditions.

Medical Uses of Mifepristone

Mifepristone has been studied and used for several medical conditions:

  • Pregnancy Termination: It’s commonly used for ending early pregnancies[3].
  • Uterine Fibroids: These are non-cancerous growths in the uterus. Mifepristone has shown promise in reducing their size and associated symptoms[4].
  • Cushing’s Syndrome: This is a condition where the body produces too much of the hormone cortisol. Mifepristone can help manage its symptoms[5].
  • Certain Cancers: Research is ongoing to explore its potential in treating brain tumors, breast cancer, and other types of cancer[6][7].
  • Mental Health Conditions: Some studies have investigated its use in treating bipolar depression[2].
  • Adrenal Insufficiency: It’s being studied as a diagnostic tool for this condition, where the adrenal glands don’t produce enough hormones[8].

How Mifepristone Works

Mifepristone works by blocking the effects of certain hormones in the body:

  • Progesterone Blocker: It prevents the hormone progesterone from working normally. This is how it can end early pregnancies and help with conditions like uterine fibroids[4].
  • Cortisol Blocker: It also blocks the effects of cortisol, a stress hormone. This is why it’s useful in treating Cushing’s syndrome[5].
  • Hormone Receptor Interactions: In some cancers, it may work by interfering with hormone receptors that help cancer cells grow[7].

Dosage and Administration

The dosage of mifepristone varies depending on what it’s being used to treat:

  • For Pregnancy Termination: Usually a single dose of 200mg, followed by another medication called misoprostol[3].
  • For Uterine Fibroids: Doses ranging from 5mg to 10mg daily have been studied[4].
  • For Cushing’s Syndrome: Doses can range from 300mg to 1200mg per day[5].
  • For Cancer Studies: Various doses have been used, often around 300mg daily[1].

It’s important to note that mifepristone should only be taken under the close supervision of a healthcare provider, as the dosage needs to be carefully controlled and monitored.

Potential Side Effects

Like all medications, mifepristone can cause side effects. These can include:

  • Nausea and vomiting
  • Fatigue or tiredness
  • Dizziness
  • Headache
  • Skin rash
  • Changes in menstrual bleeding

In some cases, more serious side effects can occur. It’s crucial to discuss all potential risks and side effects with your doctor before starting treatment[8].

Ongoing Research and Future Potential

Scientists are continually studying mifepristone to understand its full potential:

  • Cancer Treatment: Researchers are investigating its use in various types of cancer, including breast cancer and lung cancer[7][1].
  • Mental Health: Studies are exploring its potential in treating conditions like bipolar depression[2].
  • Diagnostic Tool: It’s being studied as a way to diagnose certain hormone-related conditions[8].

These ongoing studies may lead to new uses for mifepristone in the future, potentially expanding its role in medical treatment.

Condition Mifepristone Dosage Key Findings/Objectives
Bipolar Depression 600 mg daily for 7 days Investigating effects on depressive symptoms and cognition
Brain/Nervous System Cancers 200 mg daily Compassionate use to prevent cancer progression
Uterine Fibroids 5 mg or 10 mg daily for 3 months Aiming to reduce fibroid volume by about 40%
Central Adrenal Insufficiency 600 mg single dose Evaluating mifepristone as a diagnostic tool
Post-Traumatic Stress Disorder Varied Examining cortisol receptor function in PTSD
Cushing’s Syndrome 300-1200 mg daily Assessing safety and efficacy in treating symptoms
Non-Small Cell Lung Cancer 300 mg daily Evaluating as salvage therapy after failed chemotherapy

FAQ

  • What is mifepristone and how does it work? Mifepristone is a medication that acts as an antagonist to certain hormones in the body. It primarily blocks the effects of progesterone and cortisol by binding to their receptors. This mechanism allows it to have various effects on different medical conditions.
  • In which medical conditions is mifepristone being studied? Clinical trials are exploring the use of mifepristone in conditions such as bipolar depression, certain types of cancer (including brain, breast, and lung cancers), uterine fibroids, Cushing's syndrome, post-traumatic stress disorder (PTSD), and central adrenal insufficiency.
  • What are the potential benefits of using mifepristone for uterine fibroids? Studies have shown that mifepristone may help reduce the volume of uterine fibroids and alleviate associated symptoms. Clinical trials are comparing different doses (5 mg vs 10 mg) to determine the most effective treatment regimen.
  • How is mifepristone being used in cancer research? Mifepristone is being investigated as a potential treatment for various types of cancer, including brain tumors, breast cancer, and non-small cell lung cancer. Some studies are exploring its use as a compassionate treatment option for patients who have not responded to other therapies.
  • Are there any side effects associated with mifepristone use in clinical trials? As with any medication, mifepristone can have side effects. In clinical trials, researchers carefully monitor participants for adverse events. Common side effects may include nausea, fatigue, and changes in hormone levels. The specific side effects can vary depending on the condition being treated and the dosage used.

Ongoing Clinical Trials on Mifepristone

  • Comparing hysteroscopic surgery to mifepristone and misoprostol treatment for early pregnancy loss in women under 10 weeks of pregnancy

    Recruiting

    3 1 1 1
    Investigated drugs:
    Belgium

  • Study of oxytocin, dinoprostone, and misoprostol combination for active management in pregnant women with premature rupture of membranes

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on Mifepristone for Patients with Treatment-Resistant Post-Traumatic Stress Disorder (PTSD)

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Mifepristone and Letrozole for Treating Ectopic Pregnancy in Comparison to Methotrexate

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark Latvia Sweden

  • Study on the Effectiveness and Safety of Mifepristone 50 mg Weekly for Contraception in Women

    Not recruiting

    3 1 1
    Investigated drugs:
    The Netherlands

Glossary

  • Mifepristone: A medication that acts as an antagonist to progesterone and cortisol receptors, used in various medical treatments and being studied for its potential in treating multiple conditions.
  • Bipolar Depression: A mental health condition characterized by alternating periods of depression and mania, which is being studied as a potential target for mifepristone treatment.
  • Uterine Fibroids: Non-cancerous growths in the uterus that can cause symptoms such as heavy menstrual bleeding and pelvic pain, which may be treated with mifepristone.
  • Cushing's Syndrome: A hormonal disorder caused by prolonged exposure to high levels of cortisol, which is being investigated as a condition that may respond to mifepristone treatment.
  • Post-Traumatic Stress Disorder (PTSD): A mental health condition triggered by experiencing or witnessing a terrifying event, which is being studied in relation to mifepristone's effects on stress hormones.
  • Central Adrenal Insufficiency: A condition where the body doesn't produce enough cortisol due to problems with the pituitary gland or hypothalamus, which is being investigated using mifepristone as a diagnostic tool.
  • Hypothalamic-Pituitary-Adrenal (HPA) Axis: A complex set of interactions between the hypothalamus, pituitary gland, and adrenal glands, which plays a crucial role in the body's response to stress and is often studied in relation to mifepristone's effects.
  • Glucocorticoid Receptor (GR): A receptor protein that binds to cortisol and other glucocorticoids, which is one of the primary targets of mifepristone in its various medical applications.
  • Compassionate Use: A treatment option that allows the use of an unauthorized drug for a serious or life-threatening illness when no satisfactory authorized therapies are available.

References

  1. https://clinicaltrials.gov/study/NCT02642939
  2. https://clinicaltrials.gov/study/NCT00359125
  3. https://clinicaltrials.gov/study/NCT00190294
  4. https://clinicaltrials.gov/study/NCT00712595
  5. https://clinicaltrials.gov/study/NCT01371565
  6. https://clinicaltrials.gov/study/NCT00832871
  7. https://clinicaltrials.gov/study/NCT06099769
  8. https://clinicaltrials.gov/study/NCT04588688